These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 16381315)
61. Relationship between hormone receptor concentration and tumor shrinkage in uterine myoma after treatment with a GnRHa. Wang PH; Lee WL; Chao HT; Shu LP; Kao HL; Wu CW; Yuan CC Zhonghua Yi Xue Za Zhi (Taipei); 1999 May; 62(5):294-9. PubMed ID: 10389284 [TBL] [Abstract][Full Text] [Related]
62. Research on genesis of adipocytic metaplasia in uterine fibroids. Sośnik H; Jeleń M; Kosiński M; Sośnik K Pol J Pathol; 2015 Dec; 66(4):403-9. PubMed ID: 27003773 [TBL] [Abstract][Full Text] [Related]
63. Phosphor/sulphur ratio: an indicator of malignant uterus change. Patai K; Dévényi L; Hubay M; Csömör S; Zelkó R Oncol Res; 2005; 15(4):215-7. PubMed ID: 17822281 [TBL] [Abstract][Full Text] [Related]
64. Immunohistochemical Expression of the SERPINA3 Protein in Uterine Fibroids. de Mezer M; Markowska A; Markowska J; Krzyżaniak M; Grabarek BO; Pokusa F; Żurawski J Curr Pharm Biotechnol; 2024; 25(13):1758-1765. PubMed ID: 38204235 [TBL] [Abstract][Full Text] [Related]
65. Morphofunctional characteristics of the ovaries in proliferative uterine myoma. Pailodze MV; Daneliya GS; Dgebuadze MA Bull Exp Biol Med; 2006 Mar; 141(3):375-7. PubMed ID: 17073164 [TBL] [Abstract][Full Text] [Related]
66. Uptake and phosphorylation of 2-deoxy-D-glucose by normal human uterine muscles and uterine myomata. Goldberg E; Rosenblum I Experientia; 1968 Jul; 24(7):700. PubMed ID: 5705238 [No Abstract] [Full Text] [Related]
67. Comparative assays of tissue plasminogen activator in myometrium, cervix, and fibromyomas of the human uterus. Glas-Greenwalt P; Beller FK; Astrup T Am J Obstet Gynecol; 1971 Jul; 110(5):721-5. PubMed ID: 4254605 [No Abstract] [Full Text] [Related]
68. Application of electron spin resonance for evaluation of the level of free radicals in the myometrium in full-term pregnancy with normal labour and uterine inertia. Zyrianov VV; Sumovskaya AY; Shostak AA J Biosci; 2003 Feb; 28(1):19-21. PubMed ID: 12682420 [TBL] [Abstract][Full Text] [Related]
69. Possible link between familial susceptibility to cancer and the level of oxidative stress in thyroid cancer patients. Javakhishvili I; Mardaleishvili K; Buleishvili M; Mantskava M; Chkhikvishvili I; Kalmakhelidze S; Kipiani N; Sanikidze T Hered Cancer Clin Pract; 2024 Aug; 22(1):15. PubMed ID: 39180118 [TBL] [Abstract][Full Text] [Related]
70. [Morpho-functional parameters of the corpus luteum in healthy women and in patients of reproductive age with uterine myoma]. Daneliia GS; Paĭlodze MV; Dgebuadze MA; Matitashvili SG Morfologiia; 2006; 129(1):76-80. PubMed ID: 17201326 [TBL] [Abstract][Full Text] [Related]
71. Overexpression of myosin is associated with the development of uterine myoma. Zhang W; Cheng Z; Qu X; Dai H; Ke X; Chen Z J Obstet Gynaecol Res; 2014 Sep; 40(9):2051-7. PubMed ID: 25181625 [TBL] [Abstract][Full Text] [Related]
72. [Comparative histology of myomatous and muscular tissue from the uterus]. Meipalu VE; Sillastu VA Vopr Onkol; 1968; 14(10):41-6. PubMed ID: 5724797 [No Abstract] [Full Text] [Related]
73. [Hypertrophy of smooth muscle cells as an element of the pathogenesis of rapid growth of a myomatous node]. Shelest VN Akush Ginekol (Mosk); 1987 Jul; (7):16-9. PubMed ID: 3688322 [No Abstract] [Full Text] [Related]
74. [Oxidative metabolism of uterine smooth muscular tissue in norm and neoplastic growth (clinical and experimental studies)]. Paĭlodze MV; Sanikidze TV Morfologiia; 2005; 127(3):55-8. PubMed ID: 16381315 [TBL] [Abstract][Full Text] [Related]